Skip to Content

Lithium Extended-Release Tablets

Last Updated: March 30, 2011
Status: Resolved

Reason for the Shortage

  • West-Ward was unable to provide a reason for the shortage.
  • GlaxoSmithKline discontinued Eskalith CR in 2006.

Estimated Resupply Dates

  • Glenmark Generics has available lithium 300 mg extended-release tablets in 100 count (NDC 68462-0223-01) and 450 mg extended-release tablets in 100 count (NDC 68462-0224-01).
  • Roxane has available lithium 300 mg extended-release tablets in 100 count (NDC 00054-0021-25) and 500 count (NDC 00054-0021-29), and 450 mg extended-release tablets in 100 count (NDC 00054-0020-25).
  • West-Ward has available lithium 450 mg extended-release tablets (NDC 00143-1277-01) in 100 count.

Related Shortages

Updated

March 30, 2011; February 23, 2011; February 16, 2011; February 4, 2011; January 26, 2011; January 21, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide